AgeX Therapeutics, Inc. AGE
11.10 +11.10
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 34.00K | 144.00K | 361.00K | 1.73M | 1.40M | |
| 21.00K | 125.00K | 335.00K | 1.48M | 1.03M | |
| -6.96M | -7.49M | -9.99M | -12.56M | -11.24M | |
| -10.46M | -8.68M | -10.87M | -12.15M | -7.50M | |
| -0.28 | -0.23 | -0.29 | -0.33 | -0.21 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 695.00K | 634.00K | 527.00K | 2.35M | 6.71M | |
| 3.24M | 3.15M | 3.92M | 7.44M | 10.67M | |
| 20.56M | 15.03M | 9.32M | 4.83M | 2.44M | |
| 18.12M | 13.20M | 6.30M | 1.96M | 0 | |
| -17.21M | -11.83M | -5.12M | 2.22M | 7.45M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -5.94M | -7.86M | -7.82M | -10.16M | -8.00M | |
| 6.00M | 7.25M | 5.96M | 6.26M | 6.00M | |
| 61.00K | 57.00K | -1.88M | -4.25M | -668.00K |